UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED DECEMBER 31, 2007
3 months
3 months
9 months
9 months
Year
PARTICULARS
ended
ended
ended
Ended
ended
31/12/2007
31/12/2006
31/12/2007
31/12/2006
31/03/07
Unaudited
Unaudited
Unaudited
Unaudited
Audited
Gross Sales/Operational Income
11551.07
9530.83
32814.58
22535.43
35610.58
Less Excise Duty
178.43
248.48
535.99
585.97
689.92
Net Sales/Operational Income
11372.63
9282.35
32278.59
21949.46
34920.65
Others Income
355.29
9.57
922.91
24.47
286.20
TOTAL EXPENDITURE :
9519.28
7705.20
27193.09
17717.44
28851.37
(a) (Increase)/decrease in stock in trade
(750.13)
(33.36)
(660.13)
(761.50)
(1254.16)
(b) Consumption of Raw Material
3635.09
2393.58
8482.97
8085.32
10992.29
(c) Purchase of traded goods
5201.57
4022.86
14854.59
6093.20
12961.48
(d) Staff Cost
252.84
231.31
764.57
624.78
907.93
(e) Other expenditure
1179.91
1090.81
3751.09
3675.63
5243.83
Interest
675.81
605.82
2015.83
1630.47
2587.57
Depreciation
385.89
307.24
1144.58
880.51
1224.33
Provision for Impairment of Assets
225.00
0.00
0.00
0.00
0.00
Profit(+)/Loss(-) before tax
921.95
673.66
2623.01
1745.52
2543.59
Provision for taxation
60.35
84.96
252.54
220.60
320.05
Provision for fringe benefit tax
3.57
2.03
8.37
7.48
14.05
Net Profit/Loss before Deferred Tax
858.02
586.66
2362.10
1517.43
2209.49
Provision for deferred tax
135.00
35.02
385.72
92.17
273.11
Net Profit/Loss
723.02
551.65
1976.38
1425.25
1936.38
Paid up Equity Share Capital
2283.60
2250.10
2283.60
Reserve excluding revaluation reserves
20852.17
19234.72
18875.39
EPS Rs. Basic
3.17
2.50
9.07
6.45
8.72
Diluted
3.03
2.50
8.19
6.45
8.62
Aggregated on Non-Promoters Shareholding
No. of Shares
15747004
15704594
15704594
% of Shareholding
68.96%
69.80%
68.77%
Notes:
1
During the quarter under review the total turnover of Company increased by 22.52%,
whereas the export turnover is increased by 40.86%. The Net Profit after tax has
increased by 31.07% over the corresponding figures of previous year quarter.
2
Company has internally identified certain Equipments/ Assets that have not been
productively used in Production Line due to rap rapid technological changes in the
processes/ products & other developments. Company has made a provision of Rs.225
Lacs on account of impairment of such assets as per the provision of AS-28.
3
The Board has allotted 11,96,000 equity shares to Promoters Group upon the conversion
of 11,96,000 Zero Coupon W warrants.
4
Information on Investor Complaints for the quarter: Opening Balance 1, Received
11, Redressed 11, closing Balance 1.
5
The previous period figures have been re-grouped and re-arranged wherever necessary.
6
The Company is exclusively in the Pharmaceutical business segment.
7.
The above results were taken on record by the Board of Directors in its meeting
held on 29th January, 2008.
